3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Breast Neoplasms
11
Agnosia
6
Urinary Bladder Neoplasms
4
Neoplasms
4
Lung Neoplasms
4
Pancreatic Neoplasms
3
Pain, Postoperative
3
Recurrence
2
Neoplastic Cells, Circulating
2
Neoplasm Metastasis
2
Leiomyoma
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Anesthesia
2
Acute Pain
2
Uterine Neoplasms
1
Uterine Hemorrhage
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Respiratory Aspiration
1
Pulmonary Atelectasis
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Postoperative Nausea and Vomiting
1
Postoperative Hemorrhage
1
Postoperative Complications
1
Pneumothorax
1
Pleural Neoplasms
1
Pleural Effusion, Malignant
1
Interventions
Cisplatin
28
Pemetrexed
24
pembrolizumab
12
Nivolumab
10
Carboplatin
9
atezolizumab
7
Gemcitabine
7
Cyclophosphamide
7
durvalumab
6
Drug Therapy
6
sodium thiosulfate
5
Radiotherapy, Intensity-Modulated
5
tremelimumab
4
aldesleukin
4
Radiotherapy
4
Interleukin-2
4
sargramostim
3
Vinorelbine
3
Platinum
3
Photochemotherapy
3
Ipilimumab
3
Doxorubicin
3
Dihematoporphyrin Ether
3
Chemotherapy, Adjuvant
3
Cerebral Decortication
3
vatalanib
2
regorafenib
2
niraparib
2
lenvatinib
2
cemiplimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Mesothelioma, Malignant
×
Anesthesia, General
×
Clear all
NCT05077111
2021-10-14
VATS
Ain Shams University
Phase 4
Unknown
40 enrolled